217 
I am not familiar with the presentation made by Dr. Beers. The last 
word I had was that Miles Laboratories was not directly engaged in recombi- 
nant DNA research, although they were supporting academic research. 
DR. FREDRICKSON: Mr. Helms. 
MR. HELMS: Do I understand you position to be — Let's assume arguendo 
that this report is accurate. Would you on behalf of your Association 
discourage that activity by Miles Laboratories? 
DR. ADAMS: Yes, we would. 
DR. FREDRICKSON: Mr. Beaty. 
MR. BEATY: Would you clarify, Dr. Fredrickson, whether or not, if this 
was the only stated activity, would it be in violation of the present Guide- 
lines? As I understand it, work with some B. subt i 1 i s host-vector systems 
right now is not in violation; in fact, approval has been given. Can you 
clarify that, Dr. Gartland? 
DR. GARTLAND: Yes, the B. subtilis under the current Guidelines would 
fall under alternate host-vector systems, which at the present time are being 
reviewed on a case-by-case basis; and within the past several months the 
committee and the NIH has approved the use of certain B^ subt i 1 is systems for 
c loning. 
DR. ADAMS: In a situation of this kind, we certainly would recommend 
that the company, or any other company, consult with Dr. Gartland, in the 
Office of Recombinant DNA Activities. 
DR. FREDRICKSON: I think that we will move on to one more of the invited 
witnesses before coffee, and that is Dr. Chilton, if she is here. 
DR. CHILTON: No, I don't have anything. 
DR. FREDRICKSON: You have nothing? Thank you, Dr. Chilton, then that 
will allow us time for Dr. Duvick. 
DR. DUVICK: I really have very little to say. I would like to call 
your attention to some communications, some of which you have, which say 
better than I can some things I would like to bring before you. 
The communication from the National Science Foundation which I think 
you got yesterday with the statement of the Committee on laboratory-created 
biohazards says, in one part: "The potential benefits of such research to 
the agricultural sciences, and the magnitude of future efforts needed to 
exploit these benefits, suggests the need for improved mechanisms whereby 
viewpoints in this area can be brought to the attention of the Advisory 
Committee. This can be done by establishing one or more panels to consider 
[ 421 ] 
